Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Strahlenther Onkol ; 2023 Aug 28.
Article in English | MEDLINE | ID: mdl-37638976

ABSTRACT

PURPOSE: Demographic change will lead to an increase in age-associated cancers. The demand for primary treatment, especially oncologic therapies, is difficult to predict. This work is an attempt to project the demand for radiation therapy (RT) in 2030, taking into account demographic changes using prostate cancer (PC) as an example. MATERIALS AND METHODS: Using the GENESIS database of the Federal Statistical Office, we retrieved demographic population projections for 2030 and retrospective demographic surveys from 1999 to 2019. Additionally, we queried incidence rates for PC in the respective age groups of 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, and +85 years from 1999-2019 via the Federal Cancer Registry of the Robert Koch Institute. We used a regression method to determine the age-dependent correlation between the incidence of PC and the population size of the respective age group by combining the data from 1999 to 2019. This information was used to calculate the incidence rates in the age groups of the expected population for 2030 and the expected new cases of PC in 2030. Finally, we extrapolated the indications for the demand for RT based on data from the Report on Cancer Incidence in Germany from 2016. RESULTS: Considering a population-dependent incidence rate, an increase in new cases of PC is expected. This increase is particularly evident in the age groups of 70-74 and 80-84 years. With regards to RT, the estimate indicates an overall increase of 27.4% in demand. There is also a shift in RT demands towards older patients, especially in the 80- to 84-year-old age group. CONCLUSION: We observe an age-associated increase in primary cases of PC. This is likely to result in an increased demand for RT. The exact demand cannot be predicted. However, trends can be estimated to plan for the demand. This, though, requires a good database from cancer registries.

2.
J Neurooncol ; 138(3): 571-579, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29520609

ABSTRACT

There is no standard treatment available for recurrent high-grade gliomas. This monoinstitutional retrospective analysis evaluates the differences in overall survival and progression-free survival in patients according to the timing of re-irradiation. Patients suffering from a glioblastoma who received re-irradiation for recurrence were evaluated retrospectively. The median overall survival (OS) and the median progression-free survival were compared with different treatment options and within various time periods. From January 2007 until March 2015, 41 patients suffering from recurrent high-grade gliomas received re-irradiation [median dose of 30.6 Gy (range 20-40 Gy) in median 4 Gy fractions (range 1.8-5 Gy)] in our institution after initial postoperative irradiation or combined radiochemotherapy. The OS in this population was 34 months, and the OS after recurrence (OS-R) was 13 months. After diagnosis of recurrence, patients underwent additional surgical resection after a median of 1.2 months, received a second-line systemic therapy after 2.2 months with or without re-irradiation after 5.7 months. Growth of the tumour was assessed 4.3 months after the start of re-irradiation. The OS after the second surgical resection was 12.2 months, 11.7 months after the start of the second-line systemic therapy, and 6.7 months after the start of re-irradiation. The OS-R was not significantly correlated with the start of re-irradiation after a diagnosis of recurrence or the time period after the previous surgery. At this institution, re-irradiation was performed later compared to other treatment options. However, select patients could benefit from irradiation at an earlier time point. A precise time point should still be evaluated on an individual basis due to the patient's diverse conditions.


Subject(s)
Brain Neoplasms/radiotherapy , Glioma/radiotherapy , Neoplasm Recurrence, Local/radiotherapy , Re-Irradiation , Brain Neoplasms/mortality , Brain Neoplasms/pathology , Disease Progression , Dose Fractionation, Radiation , Female , Glioma/mortality , Glioma/pathology , Humans , Male , Middle Aged , Neoplasm Grading , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/pathology , Retrospective Studies , Survival Analysis , Time-to-Treatment
3.
Virchows Arch ; 469(3): 339-44, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27392930

ABSTRACT

Purpose of this study was to evaluate prognostic impact of rare variants of urothelial bladder cancer (BC) after treatment with combined radiochemotherapy (RCT). To this end tumour tissue of 238 patients with urothelial carcinoma (UC) treated with transurethral resection of the bladder (TUR-B) and RCT with curative intent was collected. Histomorphological analysis included re-evaluation and semi-quantitative assessment of rare UC subtypes. Additionally, human epidermal growth factor receptor 2 (HER2) chromogenic in situ hybridisation (CISH) was performed in tumours with a micropapillary component exceeding 30 %. Long-term follow-up was available for 200 patients (range 3-282 months). Variant UC histology was found in 45 of 238 tumours, most frequently micropapillary UC (N = 17) including cases with a small fraction of tumour with micropapillary morphology. The mere presence of micropapillary morphology did not affect prognosis. In tumours with extensive (≥30 %) micropapillary morphology (N = 8) Kaplan-Meier analysis revealed significantly worse cancer specific survival (CSS) (P = 0.002) compared to conventional UC (mean survival times 97 months and 229 months, respectively). Univariate Cox regression analysis of cases with ≥30 % micropapillary morphology revealed a hazard ratio of 4.726 (95 % CI 1.629-13.714) for CSS (P = 0.004). CISH revealed HER2 gene amplification in 3/10 tumours with ≥30 % micropapillary component. In conclusion, for BC treated with TUR-B and RCT, the presence of micropapillary morphology in more than 30 % of the tumour is an adverse prognostic factor. Further studies are needed to evaluate a potential benefit of different, especially multimodal treatment strategies for micropapillary UC and also other subtypes of UC. Her2 represents a promising therapeutic target in a subset of micropapillary UC.


Subject(s)
Carcinoma, Papillary/pathology , Carcinoma, Transitional Cell/diagnosis , Carcinoma, Transitional Cell/pathology , Chemoradiotherapy , Urologic Neoplasms/diagnosis , Urologic Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Papillary/diagnosis , Carcinoma, Papillary/therapy , Chemoradiotherapy/methods , Female , Humans , Male , Middle Aged , Prognosis , Urologic Neoplasms/therapy , Urothelium/pathology
4.
J Clin Pathol ; 57(11): 1225-8, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15509691

ABSTRACT

Erdheim-Chester disease is a rare non-Langerhans' cell histiocytosis with characteristic radiological and histological features. This entity is defined by a mononuclear infiltrate consisting of lipid laden, foamy histiocytes that stain positively for CD68. About half of those affected have extraskeletal manifestations, including involvement of the hypothalamus-pituitary axis, lung, heart, retroperitoneum, skin, liver, kidneys, spleen, and orbit. This report describes the case of a 50 year old white man who presented with hypogonadism and diabetes insipidus. At necropsy, extensive organ involvement was found, including the testes, thyroid, and lymph nodes. This is the first report of thyroid and lymph node infiltration in this disease. Because of the endocrinological symptoms, neurosarcoidosis and hypophysitis are important diseases in the differential diagnosis. This report also includes a review of the literature concerning rare organ manifestations and patients presenting primarily with similar symptoms.


Subject(s)
Erdheim-Chester Disease/pathology , Lymph Nodes/pathology , Testis/pathology , Thyroid Gland/pathology , Erdheim-Chester Disease/diagnosis , Fatal Outcome , Humans , Male , Middle Aged
5.
Circulation ; 101(19): 2264-70, 2000 May 16.
Article in English | MEDLINE | ID: mdl-10811593

ABSTRACT

BACKGROUND: Increased inactivation of nitric oxide by oxygen free radicals contributes to endothelial dysfunction in patients with coronary artery disease (CAD). We therefore determined the activity of extracellular superoxide dismutase (EC-SOD), the major antioxidant enzyme system of the vessel wall, and its relation to flow-dependent, endothelium-mediated dilation (FDD) in patients with CAD. METHODS AND RESULTS: SOD isoenzyme activity was determined in coronary arteries from 10 patients with CAD and 10 control subjects. In addition, endothelium-bound EC-SOD activity (eEC-SOD), released by heparin bolus injection, and FDD of the radial artery were measured in 35 patients with CAD and 15 control subjects. FDD, determined by high-resolution ultrasound, was assessed at baseline, after intra-arterial infusion of vitamin C, N-monomethyl-L-arginine, and combination of both. EC-SOD activity in coronary arteries (control subjects: 126+/-14; CAD: 63+/-11 U/mg protein; P<0.01) and eEC-SOD activity in vivo (control subjects: 14.5+/-1.1; CAD: 3.8+/-1.1 U. mL(-1). min(-1); P<0.01) were reduced in patients with CAD. Activity of eEC-SOD was positively correlated with FDD (r=0.47; P<0. 01) and negatively with the effect of the antioxidant vitamin C on FDD (r=-0.59; P<0.01). In young individuals with hypercholesterolemia, however, eEC-SOD activity was increased (21. 0+/-1.2 U. mL(-1). min(-1); n=10; P<0.05). CONCLUSIONS: In patients with CAD, vascular EC-SOD activity is substantially reduced. The close relation between endothelium-bound EC-SOD activity and FDD suggests that reduced EC-SOD activity contributes to endothelial dysfunction in patients with CAD. In young hypercholesterolemic individuals, however, endothelium-bound EC-SOD activity is increased and may, in part, counteract impairment of endothelial function as the result of increased formation of oxygen free radicals.


Subject(s)
Coronary Disease/enzymology , Coronary Vessels/enzymology , Extracellular Space/enzymology , Superoxide Dismutase/metabolism , Adult , Aged , Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Coronary Disease/physiopathology , Drug Combinations , Endothelium, Vascular/physiopathology , Enzyme Inhibitors/pharmacology , Humans , Hypercholesterolemia/enzymology , Hypercholesterolemia/physiopathology , Male , Middle Aged , Radial Artery/drug effects , Radial Artery/physiopathology , Reactive Oxygen Species/physiology , Vasodilation/drug effects , Vasodilation/physiology , omega-N-Methylarginine/pharmacology
6.
Zentralbl Gynakol ; 120(10): 521-3, 1998.
Article in German | MEDLINE | ID: mdl-9823655

ABSTRACT

The switch to the new millennium causes greater difficulties in computing concerning hard- and software. It is not foreseeable how much each computer will be hit by that. Due to the common use of computers in all parts of medicine the possible crash of data banks and networks across hospitals could afflict the regular care of patients in wards and outpatient clinics. The ability of each computer to go to the new millennium can be checked by simply performed tests or by highly specialized programmes as well. As many mistakes occur in co-operation of hardware and software, it is hard to fix the system. To continue the use of a data bank it is necessary to change the data bank's date format and all applications at the same time. Programmers and providers offer their advice via internet.


Subject(s)
Gynecology/trends , Medical Records Systems, Computerized/trends , Obstetrics/trends , Software/trends , Databases, Factual/trends , Forecasting , Germany , Hospital Information Systems/trends , Humans , Software Design
7.
Arch Kriminol ; 201(5-6): 146-56, 1998.
Article in German | MEDLINE | ID: mdl-9701749

ABSTRACT

The policemen sometimes feel the bonnet of a car for warmth to check wether it had been used just before. But in court it is difficult to quantify the temperature of the car. Therefore, 541 volunteers were given warmed steel plates to feel at different ambient temperatures between -8 degrees C and 30 degrees C and were asked to estimate their temperature. Highest and lowest temperatures for estimating metal plates as hot, warm, slightly warm or cold were measured. Combined with the known decrease of temperature after using an engine, the time at which the engine stopped can be estimated after this study. The sense of warmth and coldness turned out to be significantly influenced by the ambient temperature, by the time of day and by the volunteers' energy balance. In the morning volunteers estimated temperatures 2.5 degrees C higher and more precisely than in the afternoon and evening. For hungry volunteers the seemed 2.5 degrees C colder than for volunteers with a postprandially elevated energy balance. The lowest necessary temperature to cause a slightly warm sensation was 16 degrees C lower at -8 degrees C ambient temperature than at 30 degrees C ambient temperature. The risk of estimating a plate as warm by mistake was found in only 0.57%. Confirmed by this study, estimated temperatures can be considered reliable enough to cite in court.


Subject(s)
Discrimination, Psychological , Judgment , Thermosensing , Acclimatization , Adolescent , Adult , Aged , Female , Humans , Male , Memory, Short-Term , Middle Aged , Sensitivity and Specificity , Sensory Thresholds
SELECTION OF CITATIONS
SEARCH DETAIL
...